EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:59330 - (S)-carbinoxamine maleate
| Formula | C16H19ClN2O.C4H4O4 |
| Net Charge | 0 |
| Average Mass | 406.866 |
| Monoisotopic Mass | 406.12955 |
| SMILES | CN(C)CCO[C@@H](c1ccc(Cl)cc1)c1ccccn1.O=C(O)/C=C\C(=O)O |
| InChI | InChI=1S/C16H19ClN2O.C4H4O4/c1-19(2)11-12-20-16(15-5-3-4-10-18-15)13-6-8-14(17)9-7-13;5-3(6)1-2-4(7)8/h3-10,16H,11-12H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1-/t16-;/m0./s1 |
| InChIKey | GVNWHCVWDRNXAZ-ZSJYYTRTSA-N |
| Roles Classification |
|---|
| Biological Roles: | muscarinic antagonist A drug that binds to but does not activate muscarinic cholinergic receptors, thereby blocking the actions of endogenous acetylcholine or exogenous agonists. H1-receptor antagonist H1-receptor antagonists are the drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. muscarinic antagonist A drug that binds to but does not activate muscarinic cholinergic receptors, thereby blocking the actions of endogenous acetylcholine or exogenous agonists. H1-receptor antagonist H1-receptor antagonists are the drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. |
| Applications: | antiparkinson drug A drug used in the treatment of Parkinson's disease. anti-allergic agent A drug used to treat allergic reactions. muscarinic antagonist A drug that binds to but does not activate muscarinic cholinergic receptors, thereby blocking the actions of endogenous acetylcholine or exogenous agonists. H1-receptor antagonist H1-receptor antagonists are the drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. anti-allergic agent A drug used to treat allergic reactions. muscarinic antagonist A drug that binds to but does not activate muscarinic cholinergic receptors, thereby blocking the actions of endogenous acetylcholine or exogenous agonists. antiparkinson drug A drug used in the treatment of Parkinson's disease. H1-receptor antagonist H1-receptor antagonists are the drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. ophthalmology drug Any compound used for the treatment of eye conditions or eye diseases. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| (S)-carbinoxamine maleate (CHEBI:59330) has part (S)-carbinoxamine (CHEBI:59329) |
| (S)-carbinoxamine maleate (CHEBI:59330) has role anti-allergic agent (CHEBI:50857) |
| (S)-carbinoxamine maleate (CHEBI:59330) has role antiparkinson drug (CHEBI:48407) |
| (S)-carbinoxamine maleate (CHEBI:59330) has role H1-receptor antagonist (CHEBI:37955) |
| (S)-carbinoxamine maleate (CHEBI:59330) has role muscarinic antagonist (CHEBI:48876) |
| (S)-carbinoxamine maleate (CHEBI:59330) is a carbinoxamine maleate (CHEBI:31353) |
| IUPAC Name |
|---|
| 2-[(S)-(4-chlorophenyl)(pyridin-2-yl)methoxy]-N,N-dimethylethanamine (2Z)-but-2-enedioate |
| Synonyms | Source |
|---|---|
| 2-[(S)-(4-chlorophenyl)(pyridin-2-yl)methoxy]-N,N-dimethylethanamine maleate | ChEBI |
| levocarbinoxamine maleate | ChEBI |
| rotoxamine maleate | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| DB00748 | DrugBank |
| Registry Numbers | Sources |
|---|---|
| Beilstein:5699026 | Beilstein |